about
Tissue Specific Promoters in Colorectal CancerRole of retinoids in the prevention and treatment of colorectal cancerSerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancerJacalin Has Chemopreventive Effects on Colon Cancer Development.Aseptic splenic abscess as precursory extraintestinal manifestation of inflammatory bowel disease.Influence of ω-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women.Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes.Expression of COX-2 and HER-2 in colorectal cancer and their correlation.Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway.Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal NeoplasmsColorectal cancer carcinogenesis: a review of mechanismsThe epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiencyImmunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.Do inflammatory pathways drive melanomagenesis?A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.Pharmacogenomics of cyclooxygenases.Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.Upregulation of cyclooxygenase-2 is associated with activation of the alternative nuclear factor kappa B signaling pathway in colonic adenocarcinoma.Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma.The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation.The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization.Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.Synergistic inhibitory effect of cetuximab and tectochrysin on human colon cancer cell growth via inhibition of EGFR signal.Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)-Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APCToll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation
P2860
Q26773374-A820B82C-55E8-470A-86DB-2C8792F81D90Q26781463-56224E0E-2A72-4AC4-A97E-34E05EE33428Q30842687-ECDF50BB-D755-408A-85FD-473110661D20Q33813699-04B642FC-E037-4325-91CE-B2CEE8BFBF1FQ34222226-4FDC4BD7-86E7-4B0F-8884-3E8108E055E0Q35589228-71AC27CF-F584-4825-BF2B-947C8BED269FQ35606701-EE87F492-99BD-4536-90A7-8AC83E5CA7AEQ35651481-4933391C-FFC2-4969-A087-3AFD5BB1BBC4Q36146089-1C07BFE6-293C-4CC5-AD7A-52F79031B3B5Q36363166-8FE9C759-BFA0-4603-983C-A8537684DA86Q36412897-6225A236-17E1-46C1-BDB5-D0AE0EFE3889Q36849645-DB466984-652D-4C57-B4B3-2D2EE76D6F9BQ37220262-60A46118-ECB1-4BB8-BBC8-5C04CD29E389Q37317574-B59ED75A-9E4A-486A-93CB-571327AD44CEQ37412221-82106CCF-F6E7-4A7E-A74F-843A93483B2BQ37662128-8FC95C86-F0B6-4A97-8786-B0CFDCDF55F2Q37718295-8BCEC400-51CB-41CD-85C5-8C0269BEA124Q38231601-F30BF219-DC1E-4846-9679-4792DC1B1E5AQ38241837-FB62434D-A13E-4B35-B75A-91F8F1568E77Q38444433-D4682D00-5BB1-4D80-B690-A1D44D089409Q38773024-718D0341-05A4-4519-8B1C-0627BE9130D0Q38820857-084E4C7E-4DE0-44AC-ADD2-479F8E288AD8Q38824308-BAF9246A-D5C8-44C6-8D13-59482AD533DCQ41712337-062C6EA7-7B72-4896-AD1F-56B8D81F2781Q41926515-055CD1F9-CB52-4C80-B985-F066591994C8Q48009155-DA07761D-CEAA-4A02-ACD6-CD33B9F220CFQ48316977-65CB1B7C-AC17-4095-8CD6-00513646D387Q51141555-BD8E8114-1055-4DE9-96F7-8AE9F3172ECEQ51221296-892184E4-D03D-459F-A427-AF4D16D68F25Q54204439-F977851C-7465-42E4-906B-E9FFACCDE40CQ55412981-9F1284FC-9985-4578-B479-C8A0ECDD0E6DQ57316200-93392C36-BB99-494A-8FC1-5AEB2E7DF598Q58773124-3002BDF8-9C1F-4C8B-9C9C-60CE14020897Q58788075-EAEC4B67-3444-4C01-9454-FF86D9761D5D
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Over-expression of COX-2 mRNA in colorectal cancer.
@ast
Over-expression of COX-2 mRNA in colorectal cancer.
@en
type
label
Over-expression of COX-2 mRNA in colorectal cancer.
@ast
Over-expression of COX-2 mRNA in colorectal cancer.
@en
prefLabel
Over-expression of COX-2 mRNA in colorectal cancer.
@ast
Over-expression of COX-2 mRNA in colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Over-expression of COX-2 mRNA in colorectal cancer.
@en
P2093
Bjorn W H van Heumen
Fokko M Nagengast
Hennie M J Roelofs
Rene H M Te Morsche
Wilbert H M Peters
P2860
P2888
P356
10.1186/1471-230X-14-1
P577
2014-01-02T00:00:00Z
P6179
1050578975